Provided by Tiger Trade Technology Pte. Ltd.

Cumberland Pharmaceuticals

3.07
-0.1700-5.25%
Volume:43.99K
Turnover:135.55K
Market Cap:45.92M
PE:-16.16
High:3.22
Open:3.22
Low:3.03
Close:3.24
52wk High:6.27
52wk Low:1.85
Shares:14.96M
Float Shares:7.97M
Volume Ratio:1.46
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1900
EPS(LYR):-0.1909
ROE:-12.17%
ROA:-2.29%
PB:1.85
PE(LYR):-16.08

Loading ...

Cumberland Pharmaceuticals Partners with RedHill for Talicia

TIPRANKS
·
Oct 21, 2025

BRIEF-CUMBERLAND PHAMACEUTICALS ANNOUNCES THE ADDITION OF AN ESTABLISHED FDA APPROVED PRODUCT TO ITS COMMERCIAL PORTFOLIO

Reuters
·
Oct 20, 2025

Cumberland Pharmaceuticals and RedHill Biopharma Launch Joint Venture to Commercialize Talicia

Reuters
·
Oct 20, 2025

Cumberland Phamaceuticals Announces the Addition of an Established FDA Approved Product to Its Commercial Portfolio

THOMSON REUTERS
·
Oct 20, 2025

BRIEF-RedHill's Talicia Secures $4 Million Strategic Investment and U.S. Co-Commercialization Partnership Deal

Reuters
·
Oct 20, 2025

Redhill Biopharma Ltd - Cumberland Invests $4 Mln for 30% Stake in Co's Global Talicia Business

THOMSON REUTERS
·
Oct 20, 2025

Hochtief AG Turner Opens 284 Million Peabody Union Mixed Use Development in Nashville

Reuters
·
Oct 15, 2025

Cumberland adds Vibativ to national group purchasing agreement with Premier

TIPRANKS
·
Oct 13, 2025

Cumberland Pharmaceuticals' Vibativ® Added to National Group Purchasing Agreement With Premier, Inc.

THOMSON REUTERS
·
Oct 13, 2025

BRIEF-Cumberland Pharmaceuticals Ibuprofen Injection Product Approved In Mexico

Reuters
·
Oct 01, 2025

Cumberland Pharmaceuticals Inc - Ibuprofen Injection Product Approved in Mexico

THOMSON REUTERS
·
Oct 01, 2025

Cumberland Pharmaceuticals and Tabuk Announce Agreement to Launch Vibativ® in Saudi Arabia and Middle East

Reuters
·
Sep 29, 2025

A.J. Kazimi, Chairman and CEO, Reports Acquisition of Common Shares in Cumberland Pharmaceuticals Inc

Reuters
·
Sep 12, 2025